USD10
SLGL acciones
Acerca de Sol-Gel TechnologiesSol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
USD10
SLGL acciones
Acerca de Sol-Gel TechnologiesSol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
Estadísticas
VENTANA DE OPERACIÓN
Cerrado
ABRE A LAS
24 mar at 13:30 GMT+0
CAPITALIZACIÓN DE MERCADO
190,03 M US$
PRECIO DE APERTURA
No hay suficientes datos
BAJO (1Y)
4,02 US$
ALTO (1Y)
97,97 US$
BAJO (24H)
61,92 US$
Alza (24H)
74,99 US$
Volumen (24 h)
16,00 mil US$
0,82 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | No hay suficientes datos | No hay suficientes datos |
1 día | 65,67 US$ | |
1 semana | 75,40 US$ | |
1 mes | 82,60 US$ | |
1 año | 5,59 US$ |